Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20150815023620N8
IRCT20150815023620N8
Completed
Early Phase 1

Evaluation of effect of adding Dexmedetomidine to Lidocaine in success of inferior alveolar nerve block in patients with asymptomatic irreversible pulpitis

Tehran Azad University, Dentistry Faculty0 sites50 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsasymptomatic irreversible pulpitis.Pulpitis

Overview

Phase
Early Phase 1
Intervention
Not specified
Conditions
asymptomatic irreversible pulpitis.
Sponsor
Tehran Azad University, Dentistry Faculty
Enrollment
50
Status
Completed
Last Updated
7 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Tehran Azad University, Dentistry Faculty

Eligibility Criteria

Inclusion Criteria

  • •Having a tooth with asymptomatic irreversible pulpitis
  • •ASA Cl I,II
  • •Age (between 18\-65 ys )

Exclusion Criteria

  • •taking psychologic drugs
  • •taking sedatives/analgesics in last 24h before treatment
  • •Having allergies to anesthetics
  • •systemic disease

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
The effect of adding dexmedetomidine to lidocaine on nerve block.
IRCT2017040433210N1Vice Chancellor for Research of Ahvaz Jundishapur University of Medical Sciences60
Active, not recruiting
Phase 4
A trial to study whether dexmedetomidine, a new anaesthetic drug added to local anaesthetic ropivacaine for blocking nerves supplying upper limb improves the quality of anaesthesia.
CTRI/2013/11/004174IZAMS INSTITUTE OF MEDICAL SCIENCES HYDERABAD30
Recruiting
Phase 3
The effect of Dexmedetomidine on myocardial protection in patients undergoing Mitral valve replacement/ repairEvaluation of the effect of adding dexmedetomidine to del-Nido cardioplegia solution on myocardial protection in patients undergoing mitral valve replacement / repair.Nonrheumatic mitral valve disorders
IRCT20210713051881N1Mashhad University of Medical Sciences56
Completed
Phase 4
The effect of adding dexmedetomidine to bupivacaine in paravertebral block.nerve Block.adverse of therapeutic use
IRCT2015121212642N23Vice chancellor for research, Iran University of Medical Sciences42
Not yet recruiting
Phase 2
To asses the effects of adding Dexmedetomidine to Ropivacaine in interscallen block.Rupture of shoulder rotator cuff.Rotator cuff tear or rupture, not specified as traumaticM75.1
IRCT20181011041308N4Iran University of Medical Sciences42